Filippo Lodi
Overview
Explore the profile of Filippo Lodi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
648
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Farolfi A, Ceci F, Castellucci P, Graziani T, Siepe G, Lambertini A, et al.
Eur J Nucl Med Mol Imaging
. 2018 Jun;
46(1):11-19.
PMID: 29905907
Purpose: The primary aim of this retrospective, single-centre analysis was to assess the performance of Ga-PSMA-11 PET/CT in prostate cancer (PCa) patients in early PSA failure after radical prostatectomy (RP)....
12.
Lopci E, Grizzi F, Russo C, Toschi L, Grassi I, Cicoria G, et al.
Nucl Med Commun
. 2017 Mar;
38(4):340-346.
PMID: 28263239
Objective: The aim of this study was to analyse early and delayed acquisition on copper-64 diacetyl-bisN4-methylthiosemicarbazone (Cu-ATSM) PET/CT in a small cohort of patients by comparing semiquantitative and computer-aided fractal...
13.
Boschi S, Lee J, Beykan S, Slavik R, Wei L, Spick C, et al.
Eur J Nucl Med Mol Imaging
. 2016 Jun;
43(12):2122-2130.
PMID: 27329046
Purpose: The aim of this study was to synthesize and preclinically evaluate an F-PSMA positron emission tomography (PET) tracer. Prostate-specific membrane antigen (PSMA) specificity, biodistribution, and dosimetry in healthy and...
14.
Graziani T, Ceci F, Castellucci P, Polverari G, Maria Lima G, Lodi F, et al.
Eur J Nucl Med Mol Imaging
. 2016 Jun;
43(11):1971-9.
PMID: 27277279
Purpose: To evaluate (11)C-choline PET/CT as a diagnostic tool for restaging prostate cancer (PCa), in a large, homogeneous and clinically relevant population of patients with biochemical recurrence (BCR) of PCa...
15.
Gagliardi C, Tabacchi E, Bonfiglioli R, Diodato S, Nanni C, Guidalotti P, et al.
J Nucl Cardiol
. 2016 Mar;
24(2):746-749.
PMID: 26976144
Cardiac amyloidosis (CA) leads to variable degrees of myocardial infiltration with a final echocardiographic phenotype of "hypertrophy." Although many non-invasive imaging techniques (MRI, CT, scintigraphy, PET) are useful, the definitive...
16.
Nanni C, Zanoni L, Pultrone C, Schiavina R, Brunocilla E, Lodi F, et al.
Eur J Nucl Med Mol Imaging
. 2016 Mar;
43(9):1601-10.
PMID: 26960562
Purpose: To compare the accuracy of (18)F-FACBC and (11)C-choline PET/CT in patients radically treated for prostate cancer presenting with biochemical relapse. Methods: This prospective study enrolled 100 consecutive patients radically...
17.
Lopci E, Grassi I, Rubello D, Colletti P, Cambioli S, Gamboni A, et al.
Clin Nucl Med
. 2015 Oct;
41(2):e87-92.
PMID: 26447388
Purpose: Cu-ATSM is a very promising PET radiopharmaceutical for tumor imaging of hypoxia. One of the advantages of this compound compared with other hypoxia-avid tracers is the high tumor-to-background signal...
18.
Boschi S, Lodi F, Boschi L, Nanni C, Chondrogiannis S, Colletti P, et al.
Clin Nucl Med
. 2014 Jul;
40(2):e96-e103.
PMID: 24999701
Dysfunction of the sympathetic nervous system underlies many cardiac diseases and can be assessed by molecular imaging using SPECT tracers as I-metaiodobenzylguanidine (I-MIBG). The norepinephrine analog C-meta-hydroxyephedrine (HED) has been...
19.
Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, et al.
Am J Nucl Med Mol Imaging
. 2014 Jul;
4(4):365-84.
PMID: 24982822
Hypoxia is a pathological condition arising in living tissues when oxygen supply does not adequately cover the cellular metabolic demand. Detection of this phenomenon in tumors is of the utmost...
20.
Castellucci P, Ceci F, Graziani T, Schiavina R, Brunocilla E, Mazzarotto R, et al.
J Nucl Med
. 2014 Jun;
55(9):1424-9.
PMID: 24935990
Unlabelled: The aim of the study was to assess which factors may influence (11)C-choline PET/CT detection rate in a population of recurrent prostate cancer (PCa) patients listed for salvage radiation...